Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023] (European Urology, (S0302283823000015), (10.1016/j.eururo.2023.01.001))

Matthew S. Ernst, Vishal Navani, J. Connor Wells, Frede Donskov, Naveen Basappa, Chris Labaki, Sumanta K. Pal, Luis Meza, Lori A. Wood, D. Scott Ernst, Bernadett Szabados, Rana R. McKay, Francis Parnis, Cristina Suarez, Takeshi Yuasa, Aly Khan Lalani, Ajjai Alva, Georg A. Bjarnason, Toni K. Choueiri, Daniel Y.C. Heng

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)e166-e167
JournalEuropean Urology
Volume83
Issue number6
DOIs
Publication statusPublished - Jun 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Urology

Fingerprint

Dive into the research topics of 'Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023] (European Urology, (S0302283823000015), (10.1016/j.eururo.2023.01.001))'. Together they form a unique fingerprint.

Cite this